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Murine gammaherpesvirus is a natural pathogen ofwild mice. The virus infects alveolar cells and spleen cells
during the primary infection and establishes a latent/persistent infection in B lymphocytes. Little is known
about the immunological response to gammaherpesviruses during a primary infection. To address this issue,
we investigated the pathogenesis of murine herpesvirus 68 (MHV-68) infection in mice deficient in CD4 or CD8
T-cell populations. Infection of the lung and spleen were greatly exacerbated in CD8-deficient mice, reflected
by elevated virus titers in the lung and an increase in the number of infected splenocytes located around
germinal centers. This finding contrasts with clearance of virus from the lung and spleen by day 12
postinfection in CD4-depleted animals. These data clearly indicate a major role for CD8 T cells in recovery
from an acute MEIV-68 infection. Whereas CD4 T cells fail to influence the course of infection in the lung, they
do contribute to lymphoproliferation seen in the spleen (splenomegaly) during the primary infection. The
significance of these results are discussed in relation to the immune response to other herpesviruses, in
particular Epstein-Barr virus, with which MHV-68 shares similar molecular and biological properties.
Murine herpesvirus 68 (MHV-68) is a naturally occurring
murid herpesvirus originally isolated from bank voles
(Clethrionemys glareolus) in Czechoslovakia (1). Analysis of
the structure of the viral genome and limited sequence data
of viral genes revealed MHV-68 to be closely related to two
gammaherpesviruses of primates, Epstein-Barr virus (EBV)
and herpesvirus saimiri (3, 4). Following an intranasal inoc-
ulation of virus into BALB/c mice, a productive infection is
established in the lung, localized to alveolar epithelium and
mononuclear cells (12). As with other gammaherpesviruses,
MHV-68 is associated with lymphocytes and latent virus can
be detected in the spleen by a cocultivation assay (12). The
lymphocyte subset harboring virus during the persistent
infection has been identified as an immunoglobulin-positive
B lymphocyte (13).
The host defense mechanisms involved in the recovery
from MHV-68 infection are unknown. In other herpesvirus
infections, T lymphocytes play a key role in the destruction
of virus-infected cells and in recovery from the primary
infection. Previous studies on herpes simplex virus (HSV)
infection of mice identified an important role for virus-
specific cytotoxic T lymphocytes in protecting the nervous
system from virus infection, whereas in the skin, CD4 T cells
were the major effector cell population, possibly functioning
via the recruitment and activation of macrophages (8). In
contrast to HSV, protective immunity against murine cyto-
megalovirus infection in BALB/c mice is mediated by CD8 T
cells, recognizing an immediate-early gene product in in-
fected cells (6). CD8 T cells are also important in the control
of persistent EBV infection in humans and are probably
responsible for clearing the infection at epithelial sites (10).
However, the role of the immune response in primary EBV
infection is still largely unresolved, in part because of the
lack of any suitable animal model. Consequently, studies on
MHV-68 infection of mice may shed light on the immuno-
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logical mechanisms involved in the control of primary EBV
infection.
To investigate the role of T cells in a primary MHV-68
infection of BALB/c mice, we have used monoclonal anti-
bodies to deplete T-cell subsets in vivo (2, 8). This approach
has already been used successfully to study the role of T
cells in several virus infections, including HSV (8) and
murine cytomegalovirus (6) infections. In this report, we
demonstrate that CD8 T cells are central to recovery from a
primary infection, whereas CD4 T cells contribute little to
recovery but appear to be involved in splenomegaly, an early
pathological feature of this virus infection.
MATERIALS AND METHODS
Mice. Female BALB/c mice were obtained from Bantin
and Kingman (Grimston, Aldbrough, Hull, United Kingdom)
and were infected when 3 to 4 weeks of age.
V'irus and route of inoculation. Working stocks of MHV-68
were prepared from clone G2.4, the titer of which was 3 x
107 PFU/ml. All virus stocks were grown in BHK-21 (baby
hamster kidney) cells maintained in Glasgow modified Ea-
gle's medium supplemented with 10% tryptose phosphate
broth and 10% newborn calf serum. Each mouse was inoc-
ulated intranasally with a dose of 4 x 105 PFU of MHV-68.
The volume of inoculum was 40 ,ul per mouse, and the mice
were lightly anesthetized with ether before administration.
Virus dilutions were made in Glasgow modified Eagle's
medium immediately before use and kept on ice during the
inoculation procedure.
Intravenous and intraperitoneal administration of antibody.
Rat immunoglobulin G2b monoclonal antibodies YTS 191.1
(anti-CD4) and YTS 169.4 (anti-CD8) were used for deple-
tion of lymphocyte subsets. Mice were injected intrave-
nously in the tail with 0.1 ml of antibody at 10 mg/ml 2 days
before virus inoculation and 2 days after and then intraperi-
toneally. Details of experimental schedule are presented in
Fig. 1.
Cocultivation assay for infectious centers in the spleen. Mice
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FIG. 1. Experimental protocol for antibody treatment and tissue
sampling during MHV-68 infection of BALB/c mice. Groups of
mice: A, CD4 depleted; B, CD8 depleted; C, CD4 and CD8
depleted; D, nondepleted. Investigations: a, Spleen infectious cen-
ter assay; b, lung infectious virus assay; c, spleen cell count; d, flow
cytometric analysis. i.v., intravenous administration; i.n., intranasal
administration; i.p., intraperitoneal administration.
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were killed either by cervical dislocation or by injection of
Euthatal B.P. (Vet) anesthesia. Spleens were removed into 2
ml of RPMI 1640 supplemented with 20% fetal calf serum
(FCS) and kept individually on ice. A single cell suspension
was obtained from each spleen as previously described (13),
and the erythrocytes were removed. The leukocytes were
counted and resuspended in 4 ml of RPMI-20% FCS; 2 ml
was stored at -70°C for the infectious virus assay, and 1 ml
was used for flow cytometric analysis. The rest was diluted
(10-fold dilution series) and cocultivated with 2 x 106 BHK
cells in RPMI-20% FCS to determine the number of infec-
tious centers (12). The monolayers were fixed in 10% formal
saline and stained with 1% toluidine blue, and the number of
infectious centers was counted.
Infectious virus assay. The lungs were removed from the
three mice in each group and stored at -70°C prior to assay.
The method was as described by Sunil-Chandra et al. (12).
Briefly, the samples were homogenized, and the presence of
infectious virus was determined by plaque assay on BHK
cells. Dilutions of the lung homogenate or of the spleen cell
suspension (see above) were adsorbed with 2 x 106 BHK
cells and cultured for 4 days. The monolayers were fixed in
10% formal saline and stained with 1% toluidine blue, and
plaques were enumerated.
Flow cytometric analysis. Spleen cell suspensions from
infected mice were adjusted to 107 cells per ml in Dulbecco's
modified Eagle's medium and incubated with 50 ,ul of mono-
clonal antibody supernatant to either CD4, CD8, or CD3, or
with 50 ,ul of 1% bovine serum albumin (BSA) in phosphate-
buffered saline (PBS) with 0.1% sodium azide (wash me-
dium) as a negative control, for 30 min. The cells were
washed and incubated with 50 ,ul of STAR 49 anti-rat
fluorescein isothiocyanate conjugate (Serotec) diluted 1:100
on ice and in the dark for 30 min. The cells were washed
again and fixed in 1% formaldehyde in PBS. The cells were
analyzed by flow cytometry (Becton Dickinson FACScan
flow cytometer), using the LYSIS II application (Becton
Dickinson). The percentage of positive cells was determined
by total events obtained from the region of lymphocytes of
5,000 gated cells.
Histopathological and immunohistochemical studies. In
some experiments, the lungs and spleen were removed and
fixed immediately in 10% buffered formal saline. The tissues
were paraffin embedded, and 5-p,m thin sections were pre-
pared for histopathological studies. Sections were stained
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FIG. 2. Spleen cell numbers at different times after infection of
depleted and nondepleted mice. Groups are as indicated for each
graph. Each T-cell-depleted group is plotted against the nondepleted
group. The mean of three mice in each group is shown; horizontal
bars represent 1 standard deviation.
with hematoxylin and eosin (H&E). Indirect immunoperox-
idase labeling was used to detect virus antigen in sections
obtained from the same blocks used for H&E staining. To
avoid problems associated with overfixation of tissue spec-
imens and to allow easy penetration of reagents, the sections
were treated with 0.1% trypsin (porcine pancrease crude;
Sigma Ltd.). Tris-buffered saline was used as a diluent and
for rinsing and washing, and the slides were blocked with 5%
normal goat serum and 10% BSA in PBS to minimize
nonspecific antibody binding. Hyperimmune rabbit serum to
MHV-68 was used as the primary antibody (12). To minimize
endogenous peroxidase activity, the slides were treated with
0.75% hydrogen peroxide in methanol for 30 min before
trypsin treatment and afterwards in 0.3% hydrogen peroxide
in Tris-buffered saline for 30 min. Immunoperoxidase label-
ing using an avidin-biotin detection system was performed
with the Vectastain ABC kit (Vector Laboratories, Bretton,
Peterborough, United Kingdom).
RESULTS
Analysis of spleen T cells in MEIV-68-infected mice deficient
in CD4 and CD8 T cells. At various times after infection,
mice from different experimental groups were killed, and the
spleens were removed to quantitate the number of cells
present and to determine the T-cell phenotype by fluores-
cence-activated cell sorting analysis. In Fig. 2, the spleen
cell count for each of the T-cell subset-depleted groups is
plotted with the cell counts for the undepleted group. In mice
depleted of CD4 or both CD4 and CD8 T cells, spleen cell
numbers failed to increase relative to controls and by day 13
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FIG. 3. Flow cytometric analysis of spleen cell suspensions from
depleted and nondepleted mice. Groups are as indicated for each
graph. The graphs show the percentage positive cells for the
markers CD4, CD8, and CD3. The mean of three mice in each group
at each time point is shown; horizontal bars represent 1 standard
deviation.
had decreased in number. In contrast, in mice depleted of
CD8 T cells, the spleen cell numbers increased and in
general paralleled the values for the undepleted mice. In the
CD8-depleted and the undepleted groups, there was marked
evidence of splenomegaly.
Spleen cells taken from mice on days 6, 9, and 13
postinfection were stained for CD3, CD4, and CD8 and
analyzed by flow cytometry to check the efficiency of the
depletion procedure (Fig. 3). In mice depleted of CD4 cells,
the percentage of CD4 cells was negligible, whereas the
proportion of CD8 cells increased from 5 to over 20%.
Similarly, in the CD8-depleted group, the percentage of CD8
cells was negligible, whereas the proportion of CD4 cells
increased from 13 to over 30%. In the group depleted of CD4
and CD8 cells, both populations were absent and there were
negligible numbers of CD3+ cells, suggesting that a compen-
satory increase in T cells lacking CD4 and CD8 did not
occur.
Effect of T-cell depletion on the growth of virus in the lung
and spleen. The amount of infectious virus in the lungs of
T-cell-depleted animals was determined at different times
postinfection, using a standard plaque assay (Fig. 4). The
nondepleted group had peak virus titers on day 3, with
elimination of the virus occurring by day 9. In comparison,
the CD4-depleted group showed a more prolonged primary
infection, with peak virus titers on day 6 and elimination by
day 13. This delayed clearance of virus is also reflected in the
delayed clinical recovery of this group compared with the
nondepleted group.
Both the CD8-depleted and the CD4-plus-CD8-depleted
groups fail to clear the virus from the lung by day 13
postinfection. The high titers seen in these groups correlate
with the severity of the clinical signs observed in mice at
I
CD4 & CD8 depleted
g E
7
.g
8 5
c
0 5 10 15
Days post infection
I_
0 5 10
Days post infection
15
FIG. 4. Infectious virus titers in the lungs of depleted and
nondepleted mice. Groups are as indicated for each graph. The
mean log10 PFU per lung for three mice in each group at each time
point is shown, with data for individual mice plotted as separate
points. The limit of detection of the assay was 3.0 log10 PFU per
lung.
these time points. These data clearly indicate an important
role for CD8 T cells in the control of virus in the lung during
the primary infection.
Infectious virus was detected in the spleens of CD8-
depleted and CD8-plus-CD4-depleted animals at days 9 and
13 (approximately 2 to 3 log10 PFU). In contrast, little or no
virus was detected in spleens of the CD4-depleted and
undepleted groups. To improve the sensitivity of the assay,
the number of infectious centers was determined in the
spleen at different times postinfection (Fig. 5). On day 9,
infectious centers were detected in all groups, with the
highest number found in CD4-plus-CD8-depleted group. By
day 13, the number of infectious centers was lower in the
CD4-depleted group than in the other groups, including the
nondepleted group; it would appear that CD4 depletion is
beneficial for virus clearance from the spleen. The impor-
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FIG. 5. Infectious centers in the spleens of depleted and nonde-
pleted mice at day 9 (hatched columns) and day 13 (open columns)
postinfection. Results for individual animals are shown following
depletion of the appropriate T-cell subset as indicated. The number
of infectious centers was determined as described in Materials and
Methods and expressed as the number per 107 spleen cells.
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FIG. 6. Virus antigen distribution and histopathological changes in CD8-depleted mice at day 12 postinfection. (a) Immunoperoxidase
staining for MHV-68 antigen in the spleen (magnification, x250); arrows indicate the area magnified (x500) in panel b. (c) Immunoperoxidase
staining for MHV-68 antigen in the lung (magnification, x250). (d) H&E-stained section of the lung (magnification, x250). M, marginal zone;G, germinal center; B, bronchiole; A, alveolus; V, blood vessel; L, lymphoid cell infiltration.
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tance of CD8 cells in control of infectious centers is demon-
strated by the larger numbers of infectious centers in both
the CD8-depleted and double-depleted groups at day 13 than
in the CD4-depleted group.
Histopathological changes and virus antigen distribution in
tissues of T-cell-depleted mice. At days 6 and 12 postinfec-
tion, various tissues were removed and processed for histo-
logical examination. Sections were immunostained for
MHV-68 antigen and counterstained with H&E as described
in Materials and Methods.
At 6 days postinfection, virus was detected in the alveolar
epithelium and in mononuclear cells in the lungs of all groups
of mice. The intensity and extent of infection was greatest in
groups depleted of CD8 and both CD4 and CD8 cells. Other
tissues were largely negative at this stage, although an
occasional infected cell was detected in the spleen of mice
depleted of CD8 or both CD4 and CD8 cells. By day 12, the
pattern of staining was markedly different. In mice depleted
of CD4 cells, little or no virus antigen was detected in the
lung or spleen. Similarly, in the undepleted group, viral
antigens were absent from the lung, although an occasional
antigen-positive cell was seen in the marginal zone of spleen.
However, the lungs of both of these groups showed intense
mononuclear cell infiltration in the peribronchiolar, perivas-
cular, and interstitial areas, and there was also evidence of
organization and repair (data not shown, but similar to those
previously reported by Sunil-Chandra et al. [12]).
In the CD8-depleted mice, the majority of cells in the
interstitial area and some cells in the peribronchiolar and
perivascular tissues were positive for virus. Lymphoid cell
infiltration was seen in the perivascular and peribronchiolar
tissues but not in the interstitium. There was also evidence
of necrosis, indicating destruction of virus-infected cells. In
the spleen, several antigen-positive cells, resembling small
lymphocytes or lymphoblasts, were observed in the marginal
zones (Fig. 6). In the lungs of CD4-plus-CD8-depleted mice,
virus was detected in the perivascular areas and in the
alveolar lining cells, where extensive destruction of cells was
observed. In the spleen, large blast-like cells and cells of a
dendritic morphology were positive for virus. As with the
CD4-depleted group, there were no active germinal centers
and splenomegaly was not observed.
DISCUSSION
Much of our knowledge about the immune response to a
gammaherpesvirus infection has arisen from studies in hu-
mans infected with EBV (7, 10). These studies show the
importance of T cells in immune surveillance of latently
infected B cells; however, the immune mechanisms associ-
ated with the primary infection are largely unknown. To
investigate this area, we have used T-cell subset-deficient
mice to study a primary infection with MHV-68.
The results clearly demonstrate that CD8 lymphocytes are
needed for clearance of infectious virus from the lung and
spleen and also for control of the number of infectious
centers (presumably B cells) in the spleen. Depletion of CD8
cells results in an overwhelming MHV-68 infection, with
uncontrolled virus replication in the lung, and the mice
eventually die. In these mice, higher infectious virus titers
are detected in the lung and spleen, and these high titers
persist until the end of the experiment (day 13). In the
spleen, increased numbers of infectious centers are detected
in the groups of mice deficient in CD8 T cells. The higher
titers and delayed clearance of virus are reflected in the
severity of the clinical signs observed in these mice and in
their failure to show clinical recovery during the course of
the experiment.
Interestingly, in CD4-depleted mice, virus clearance from
the lung was only marginally delayed compared with that in
T-cell-intact mice. This finding indicates that in the absence
of CD4 T cells, CD8 T cells become activated and function to
eliminate the productive infection. However, the elimination
of virus is faster in the nondepleted group, which suggests
that CD4 cells provide help for CD8 cells to mediate an
accelerated virus clearance. In the alphaherpesvirus model
used by Nash et al. (8), clearance of HSV from infected skin
was markedly delayed in CD4-depleted mice, despite the
presence of CD8 T cells. However, in contrast to MHV-68
infection, depletion of CD8+ lymphocytes had little or no
effect on clearance of HSV from the epidermis.
In the spleens of CD8-depleted mice at day 12 postinfec-
tion, many viral antigen-positive lymphoid cells are ob-
served, scattered around the marginal zone of the germinal
centers. This is consistent with the observation that more
infectious centers are detected in the spleens of these mice
compared with the other groups. In contrast, in CD4-plus-
CD8-depleted mice, clusters of antigen-positive cells of a
dendritic morphology are seen in the red pulp. Again, these
results highlight the role of CD8 cells in clearance of virus
antigen from the spleen and show that CD4 depletion does
not have a major effect on virus clearance in this organ.
Although CD4 T cells do not contribute greatly to the
recovery from MHV-68 infection, they are involved in the
development of splenomegaly and lymphoproliferation seen
in response to the virus infection. It can be seen in Fig. 3 that
the spleen cell counts are much lower in the CD4-depleted
mice than in nondepleted mice and mice depleted of CD8 T
cells. This finding is consistent with the splenic enlargement
seen in previous experiments (12).
Since there are many similarities between EBV and
MHV-68 infections, an understanding of the early immuno-
logical events in MHV-68 infection may shed light on the
initial host response to EBV. Previous studies on EBV have
shown that CD8 T cells act as a major effector mechanism in
surveillance against persistently infected B cells; this evi-
dence is based on the recognition of EBV lymphoblastoid
cell lines by major histocompatibility complex class I-re-
stricted T cells in vitro (10). Furthermore, studies on immu-
nosuppressed transplant recipients (9, 14, 15) and on patients
with AIDS (5) shows an increase in productively infected
epithelial cells and virus shedding and in lymphoproliferative
disorders. This again highlights the importance of cell-
mediated immune responses in the control of a persistent
infection. In view of the persistence of MHV-68 in mice, it
will be interesting to determine whether T cells are important
in immunosurveillance of infected cells and suppression of
virus-triggered disease. Like EBV infection, MHV-68 infec-
tion is associated with lymphoma induction in chronically
infected animals (11). The mouse model will provide an
opportunity to study immunological control of these tumors.
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